Athens Medical Centre Buyback Yield % Related Terms
Athens Medical Centre Buyback Yield % Historical Data
* Premium members only.
The historical data trend for Athens Medical Centre's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:ACS vs HCA, THC, DVA: Buyback Yield % Comparison
For the Medical Care Facilities subindustry, Athens Medical Centre's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Athens Medical Centre (FRA:ACS) has a Buyback Yield % of 0.00 as of Jul. 06, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Athens Medical Centre and its competitors. Over the past decade, Athens Medical Centre's Buyback Yield % has ranged from 1.62 to 4.91. According to the industry distribution chart, Athens Medical Centre ranks #999999 out of 274 companies in the Healthcare Providers & Services industry.
Is Athens Medical Centre's Buyback Yield % too high?
Athens Medical Centre's current Buyback Yield % is 0.00. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 4.91. Based on the distribution chart, Athens Medical Centre ranks #999999 out of 274 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Athens Medical Centre has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's Buyback Yield % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #999999 out of 274 companies for Buyback Yield %. This places Athens Medical Centre in the lower half of its industry. Historically, Athens Medical Centre's own Buyback Yield % has ranged from 1.62 to 4.91 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Athens Medical Centre and its competitors. Athens Medical Centre's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Fairly Valued. The stock's GF Value™ is €1.72, compared to a current price of €1.61 — trading 6.7% below its estimated fair value. The current Buyback Yield % is 0.00. Athens Medical Centre's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current Buyback Yield % is 0.00 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued.
The current stock price of €1.61 is trading 6.7% below its estimated GF Value™ of €1.72.
GuruFocus considers Athens Medical Centre to be Fairly Valued.
Key valuation signals for FRA:ACS:
Buyback Yield %: 0.00
GF Value™: €1.72 vs. price of €1.61 (6.7% below fair value)
No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
69GF Score
Get the complete analysis for FRA:ACS
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ACS has been successfully added to your 
